CD274 and neoplasm: The proportion of participants with tumor PD-L1 expression in tumor and in tumor-infiltrating cells was comparable between the S-588410 (20.0% [9/45] and 37.8% [17/45], respectively) and observation (16.7% [6/36] and 27.8% [10/36], respectively) groups.